Tau-Cardia
Breakthrough Technology for the Management of Heart Failure
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in September 2022 by Amit Ashkenazi and Reuven Lewinsky, Tau-Cardia operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing a breakthrough technology for heart failure management.
Business overview
Tau-Cardia is a Health Tech & Life Sciences company developing a breakthrough technology for the management of heart failure. The company's core product is focused on medical devices within the cardiology sector, serving the healthcare and medical devices industries. Tau-Cardia operates within the Medical Devices and Medical Treatment & Therapeutics sectors, targeting providers in the healthcare market.
Log in to access full profile ›Company Intelligence Q&A
- When was Tau-Cardia founded?
- Tau-Cardia was founded in September 2022.
- Who are the founders of Tau-Cardia?
- The founders of Tau-Cardia are Amit Ashkenazi, who serves as Co-Founder & CEO, and Reuven Lewinsky, who is the CSO & Founder.
- What is Tau-Cardia's primary focus?
- Tau-Cardia is focused on developing breakthrough technology for the management of heart failure.
- In which sector does Tau-Cardia primarily operate?
- Tau-Cardia's primary sector is Health Tech & Life Sciences, specifically within Medical Devices and Medical Treatment & Therapeutics.
- What is the current product stage of Tau-Cardia?
- Tau-Cardia's product is currently in the R&D stage, as of its last update on December 29, 2024.